Vietnam Investment Review on MSN
GNTBM receives FDA approval for cancer drug phase 1 trial
TAIPEI, March 5, 2026 /PRNewswire/ -- Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results